Assignee
SULFATEQ BV
NL8 patents
Top patents by PatentIndex Score
US9913841B2Mar 13, 2018
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
SULFATEQ BV2 citations68
US10123529B2Nov 13, 2018
Compounds for protection of cells
SULFATEQ BV2 citations67
US10676452B2Jun 9, 2020
Compound for the prophylaxis or treatment of organ damage
SULFATEQ BV2 citations65
US11006626B2May 18, 2021
Compounds for protection of cells
SULFATEQ BV1 citations56
US12156862B2Dec 3, 2024
Medicaments for the treatment of vasoconstriction related diseases or disorders
SULFATEQ BV1 citations55
US11730741B2Aug 22, 2023
6-chromanol derivatives for use as a medicament
SULFATEQ BV0 citations55
US10426771B2Oct 1, 2019
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
SULFATEQ BV0 citations47
US10322124B2Jun 18, 2019
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
SULFATEQ BV0 citations47